Literature DB >> 1892773

Palliation and life quality in lung cancer; how good are clinicians at judging treatment outcome?

J Regan1, J Yarnold, P W Jones, N T Cooke.   

Abstract

A recent trial by the MRC Lung Cancer Working Party used physician assessments to compare two palliative schedules of radiotherapy in lung cancer. A prospective study has been undertaken on a subset of these trial patients to see how physician assessments of symptomatic relief and general condition correlate with patient perception of therapeutic response. In 40 patients followed up monthly from presentation until close to death, good agreement was found between doctors and patients on change in specific physical symptoms and overall physical condition. Doctors were poor judges of life quality at presentation but appeared able to identify relative improvement or deterioration in overall quality of life. In conclusion, physician assessments may constitute valid end-points for radiotherapy trials comparing palliative schedules in lung cancer.

Entities:  

Mesh:

Year:  1991        PMID: 1892773      PMCID: PMC1977492          DOI: 10.1038/bjc.1991.316

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  6 in total

1.  Radiation therapy in bronchogenic carcinoma.

Authors:  R G Slawson; R M Scott
Journal:  Radiology       Date:  1979-07       Impact factor: 11.105

2.  Palliative radiotherapy for inoperable carcinoma of the lung: final report of a RTOG multi-institutional trial.

Authors:  J R Simpson; M E Francis; R Perez-Tamayo; R D Marks; D V Rao
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-04       Impact factor: 7.038

3.  A modular approach to quality-of-life assessment in cancer clinical trials.

Authors:  N K Aaronson; M Bullinger; S Ahmedzai
Journal:  Recent Results Cancer Res       Date:  1988

4.  Treatment of inoperable carcinoma of the bronchus by megavoltage X rays.

Authors:  T J Deeley; S P Singh
Journal:  Thorax       Date:  1967-11       Impact factor: 9.139

5.  Comparison of treatment policies in inoperable bronchial carcinoma.

Authors:  K R Durrant; R J Berry; F Ellis; F R Ridehalgh; J M Black; W S Hamilton
Journal:  Lancet       Date:  1971-04-10       Impact factor: 79.321

6.  Who should measure quality of life, the doctor or the patient?

Authors:  M L Slevin; H Plant; D Lynch; J Drinkwater; W M Gregory
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

  6 in total
  5 in total

Review 1.  The impact of surgery on the multidisciplinary treatment of bronchogenic small cell carcinoma (updated review including ongoing studies).

Authors:  W Theuer; O Selawry; K Karrer
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

2.  No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients.

Authors:  Julia Riley; Joy R Ross; Dag Rutter; Athol U Wells; Katherine Goller; Ron du Bois; Ken Welsh
Journal:  Support Care Cancer       Date:  2005-06-11       Impact factor: 3.603

3.  Health economics and quality of life in cancer trials: report based on a UKCCCR workshop. United Kingdom Coordinating Committee on Cancer Research.

Authors:  R Fitzpatrick; L Davies
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

4.  Quality of life assessment in clinical cancer research.

Authors:  M Olschewski; G Schulgen; M Schumacher; D G Altman
Journal:  Br J Cancer       Date:  1994-07       Impact factor: 7.640

5.  Quality of life measurement in cancer patients receiving palliative radiotherapy for symptomatic lung cancer: a literature review.

Authors:  N Salvo; S Hadi; J Napolskikh; P Goh; E Sinclair; E Chow
Journal:  Curr Oncol       Date:  2009-03       Impact factor: 3.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.